Organon & Co | Vertriebs- Und Verwaltungskosten



Selling And Administration Expenses Veränderung Datum
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Celltrion KRW 276.8B 58.09B 2025-03
Cspc Pharmaceutical CNY 1.89B 347.81M 2025-03
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.4B 10M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
Glaxosmithkline GBP 2.7B 632M 2024-12
Kangmei Pharma CNY 209.56M 118.34M 2025-03
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 12.94M 5.87M 2024-12
Merck USD 2.63B 104M 2025-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Novartis USD 3.5B 368M 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Organon & Co USD 453M 33M 2025-06
Pharma Mar EUR 14.68M 1M 2025-06
Qiagen NV USD 148.74M 10.8M 2025-06
Sartorius EUR 225.2M 6.7M 2025-06
Sino Biopharmaceutical CNY 5.31B 1.54B 2024-12
Tilray USD 72.38M 4.99M 2024-11


Organon & Co Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.